Pharvaris NV (PHVS)
23.35
+0.58
(+2.55%)
USD |
NASDAQ |
Apr 26, 16:00
23.74
+0.39
(+1.67%)
After-Hours: 20:00
Pharvaris Enterprise Value: 824.15M for April 26, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 26, 2024 | 824.15M |
| April 25, 2024 | 792.94M |
| April 24, 2024 | 711.14M |
| April 23, 2024 | 713.29M |
| April 22, 2024 | 690.69M |
| April 19, 2024 | 598.66M |
| April 18, 2024 | 558.84M |
| April 17, 2024 | 708.45M |
| April 16, 2024 | 697.68M |
| April 15, 2024 | 651.94M |
| April 12, 2024 | 746.12M |
| April 11, 2024 | 768.18M |
| April 10, 2024 | 766.03M |
| April 09, 2024 | 812.85M |
| April 08, 2024 | 791.32M |
| April 05, 2024 | 781.64M |
| April 04, 2024 | 774.64M |
| April 03, 2024 | 767.11M |
| April 02, 2024 | 759.57M |
| April 01, 2024 | 732.13M |
| March 28, 2024 | 810.63M |
| March 27, 2024 | 831.61M |
| March 26, 2024 | 841.83M |
| March 25, 2024 | 711.12M |
| March 22, 2024 | 877.33M |
| Date | Value |
|---|---|
| March 21, 2024 | 912.30M |
| March 20, 2024 | 908.53M |
| March 19, 2024 | 965.55M |
| March 18, 2024 | 903.15M |
| March 15, 2024 | 823.54M |
| March 14, 2024 | 841.29M |
| March 13, 2024 | 831.61M |
| March 12, 2024 | 837.53M |
| March 11, 2024 | 835.91M |
| March 08, 2024 | 991.37M |
| March 07, 2024 | 985.99M |
| March 06, 2024 | 946.72M |
| March 05, 2024 | 870.34M |
| March 04, 2024 | 817.09M |
| March 01, 2024 | 867.11M |
| February 29, 2024 | 801.49M |
| February 28, 2024 | 833.48M |
| February 27, 2024 | 846.03M |
| February 26, 2024 | 867.99M |
| February 23, 2024 | 996.10M |
| February 22, 2024 | 1.020B |
| February 21, 2024 | 1.022B |
| February 20, 2024 | 985.64M |
| February 16, 2024 | 974.14M |
| February 15, 2024 | 963.16M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-127.45M
Minimum
Dec 02 2022
1.294B
Maximum
Dec 29 2023
419.28M
Average
362.44M
Median
Apr 21 2022
Enterprise Value Benchmarks
| uniQure NV | -299.44M |
| ProQR Therapeutics NV | 31.11M |
| Merus NV | 2.273B |
| argenx SE | 18.98B |
| Pharming Group | 584.99M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -35.27M |
| Total Expenses (Quarterly) | 29.27M |
| EPS Diluted (Quarterly) | -0.8185 |
| Earnings Yield | -9.21% |